AGN 0.62% 81.5¢ argenica therapeutics limited

Ann: First Patient Dosed in Phase 2 Stroke Trial of ARG-007, page-22

  1. 4,547 Posts.
    lightbulb Created with Sketch. 46
    fully funded phase two will be bought out with good efficacy.......) ...read the web investor blurb..........if unmolested $20 $25 bucks
 
watchlist Created with Sketch. Add AGN (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.